Wealth Enhancement Advisory Services LLC grew its position in Cigna Group (NYSE:CI – Free Report) by 4.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 95,023 shares of the health services provider’s stock after buying an additional 4,394 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Cigna Group were worth $27,068,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in CI. NorthCrest Asset Manangement LLC raised its holdings in shares of Cigna Group by 6.0% in the 4th quarter. NorthCrest Asset Manangement LLC now owns 11,137 shares of the health services provider’s stock valued at $3,163,000 after purchasing an additional 629 shares in the last quarter. Wedmont Private Capital lifted its position in shares of Cigna Group by 16.2% in the 4th quarter. Wedmont Private Capital now owns 7,414 shares of the health services provider’s stock worth $2,070,000 after purchasing an additional 1,031 shares during the period. Harbor Investment Advisory LLC boosted its stake in shares of Cigna Group by 15.7% during the fourth quarter. Harbor Investment Advisory LLC now owns 2,930 shares of the health services provider’s stock valued at $806,000 after purchasing an additional 398 shares in the last quarter. Wilsey Asset Management Inc. increased its holdings in Cigna Group by 5.1% during the fourth quarter. Wilsey Asset Management Inc. now owns 110,801 shares of the health services provider’s stock valued at $30,496,000 after buying an additional 5,327 shares during the period. Finally, CWA Asset Management Group LLC increased its holdings in Cigna Group by 43.2% during the fourth quarter. CWA Asset Management Group LLC now owns 1,117 shares of the health services provider’s stock valued at $307,000 after buying an additional 337 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Cigna Group Trading Up 1.6%
Shares of NYSE:CI opened at $265.78 on Wednesday. The business’s 50-day moving average is $277.46 and its 200 day moving average is $280.87. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The firm has a market capitalization of $70.04 billion, a P/E ratio of 11.98, a P/E/G ratio of 0.91 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74.
Cigna Group Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were given a dividend of $1.56 per share. The ex-dividend date of this dividend was Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is presently 28.13%.
Insider Activity at Cigna Group
In related news, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares in the company, valued at $1,638,119.70. This trade represents a 23.26% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their position. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by insiders.
Analyst Ratings Changes
CI has been the subject of a number of analyst reports. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. UBS Group reaffirmed a “buy” rating and set a $375.00 price objective on shares of Cigna Group in a research report on Monday, February 9th. Mizuho set a $325.00 target price on shares of Cigna Group in a report on Friday, January 9th. Leerink Partners increased their price target on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research report on Friday, February 6th. Finally, Barclays lowered their price target on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a report on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $333.11.
Get Our Latest Report on Cigna Group
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Read More
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
